08.01.24
On July 22 and July 23, HHS OIG published two advisory opinions for proposals by pharmaceutical manufacturers to provide fertility support to patients receiving their gene therapies.
During a July 23 hearing with executives of the nation’s three largest pharmacy benefit managers (PBMs) members of the House Committee on Oversight and Accountability made clear their concern over the role of PBMs in drug pricing and the future of independent retail pharmacies.
On July 8, Substance Abuse and Mental Health Services Administration (SAMHSA) released two Notices of Funding Opportunities directing $27.5 million to initiatives addressing behavioral health care for women.
07.31.24
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI, and state legislative activity introduced between January 1 and March 31st, 2024.
Our analysis found that hospitals disproportionately serving historically marginalized populations (HMPs) faced financial payment disparities not experienced by other hospitals, a result of both greater reliance on Medicaid reimbursements and less favorable commercial payment rates.
07.30.24
During the first half of 2024, nineteen states passed laws entering them into an array of different interstate compacts.
07.25.24
In July, CMS approved six new Reentry Section 1115 Demonstrations in Illinois, Kentucky, New Hampshire, Oregon, Utah, and Vermont.
Safety net hospitals play a vital role in serving marginalized communities, however, their efforts to advance health equity are undermined because in many states Medicaid payment rates do not cover costs.
07.24.24
The Centers for Medicare & Medicaid Services (CMS) finalized the second part of its guidance on implementation of the IRA’s Medicare Prescription Payment Plan (MPPP), known informally as Part D monthly out of-pocket “smoothing”.
On July 12, CMS released a companion guide to the Ensuring Access to Medicaid Services final rule (the “Access Final Rule”).